Medtronic Competitors or Alternatives

Medtronic's top competitors include Boston Scientific, C. R. Bard and Abbott.

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Medtronic's company profile

Geoffrey S. Martha

Chairman & CEO

72/100
95,000
$3.4B
$33.2B
1
Medtronic's Competitor - Boston Scientific logo

Michael F. Mahoney

Chairman & CEO

70/100
45,000
$2.1B
$16.7B
2
Medtronic's Competitor - C. R. Bard logo

CEO

- -
10,000 - 50,000
- -
$1B - 5B
3
Medtronic's Competitor - Abbott logo

Robert B. Ford

Chairman & CEO

82/100
115,000
$6.9M
$42B
4
Medtronic's Competitor - Baxter logo

Brent Shafer

Interim-CEO

- -
60,000
$2.5B
$10.6B
5
Medtronic's Competitor - BD logo

Thomas Polen

Chairman & CEO

66/100
77,000
$24M
$20.6B

Medtronic VS Boston Scientific

Boston Scientific CEO Michael F. Mahoney has an approval rating of 79 out of 100. Boston Scientific has an employee count of 45,000. Medtronic outnumbers Boston Scientific with 90,000. That is double the employee count of Boston Scientific. With an annual revenue of $13B, Boston has a smaller total avenue revenue than that of Medtronic. Medtronic’s annual revenue totals $30.8B. Boston Scientific has 73 subsidiaries with its latest acquisition of Acotec Scientific Holdings Limited occurring in Dec 2022. The most recent round of funding Boston Scientific has received was May 2020 when Boston Scientific raised $1.7B in a debt round. Boston Scientific saw revenue increase from $12.68B in Dec 2022 to $13.04B in Mar 2023. Boston Scientific won two Edison Awards in May 2023. Layoffs were announced in early May 2023 for Boston Scientific’s Houston staff. The latest change in leadership at Boston Scientific was the addition of Kathryn Unger as VP of Environmental, Social and Governance in Sep 2022.

Medtronic VS Abbott

The Abbott CEO Robert B. Ford has an approval rating of 83 out of 100. Ford’s approval rating is higher than Medtronic CEO Geoffrey S. Martha, who has an approval rating of 74 out of 100. Abbott has an employee count of 115,000 and an annual revenue of $41.5B. Compared to Medtronic’s employee count of 95,000 and total annual revenue of $30.8B, Abbott outnumbers Medtronic in both number of people employed and the total revenue generated annually. Abbott has 22 subsidiaries with its latest acquisition of Cardiovascular System, Inc. occurring Feb 2023. Abbott's last funding round tool place over 10 years ago, in Feb 2011 for a total of $100K. It was reported in May 2023 that Abbott saw a decrease in revenue from $43.65B in Dec 2022 to $41.51B in Mar 2023. This followed a previous revenue decline for Abbott from $45.03B in Sep 2022 to $43.65B in Dec 2022. The latest leadership news to come out of Abbott was the announcement of Jennifer Jone-McMeans as Divisional VP of Global Clinical Affairs of Abbott Vascular in Apr 2022.

Medtronic VS Johnson & Johnson

Johnson & Johnson CEO Joaquin Duato has an approval rating of 61 out of 100. This number is lower than the Medtronic CEO’s approval rating. Geoffrey S. Martha, Medtronic CEO has an approval rating of 74 out of 100. Johnson & Johnson’s total annual revenue is $96.3B. This is significantly greater than the total annual revenue Medtronic has generated. Medtronic’s annual revenue is $30.8B. Johnson & Johnson employs 152,700 people while Medtronic has an employee count of 95,000. Johnson & Johnson’s employee count is greater than that of Medtronic’s. Johnson & Johnson has 44 subsidiaries with its latest acquisition of Abiomed, Inc. for $16.6B occurring in Nov 2022. Feb 2023 saw John C. Reed join Johnson & Johnson as Executive VP of Pharmaceuticals, Research and Development.

Frequently Asked Questions about Medtronic

  1. Who are Medtronic's top competitors?

    Medtronic's top 3 competitors are Boston Scientific, C. R. Bard, Abbott.
  2. Who is similar to Medtronic?

    Boston Scientific is the most similar to Medtronic. C. R. Bard and Abbott are also similar to Medtronic.
  1. Are Medtronic and Boston Scientific competitors?

    Yes, Boston Scientific is one of Medtronic’s top competitors.